Motivation: Serum lipids have been traditionally studied in the context of lipoprotein particles. Today's emerging lipidomics technologies afford sensitive detection of individual lipid molecular species, i.e. to a much greater detail than the scale of lipoproteins. However, such global serum lipidomic profiles do not inherently contain any information on where the detected lipid species are coming from. Since it is too laborious and time consuming to routinely perform serum fractionation and lipidomics analysis on each lipoprotein fraction separately, this presents a challenge for the interpretation of lipidomic profile data. An exciting and medically important new bioinformatics challenge today is therefore how to build on extensive knowl...
Background: Advances in mass spectrometry and lipidomics techniques are providing new insights into ...
Introduction: Blood-based sample collection is a challenge, and dried blood spots (DBS) represent an...
Increased plasma cholesterol is a known risk factor for cardiovascular disease. Lipoprotein particle...
Motivation: Serum lipids have been traditionally studied in the context of lipoprotein particles. To...
Monitoring cholesterol levels is strongly recommended to identify patients at risk for myocardial in...
Abstract Background: Quantitative lipoprotein analytics using nuclear magnetic resonance (NMR) spec...
Lipids are ubiquitous in the human organism and play essential roles as components of cell membranes...
Obesity is associated with changes in the plasma lipids. Although simple lipid quantification is rou...
The focus of the present study was to define the human plasma lipidome and to establish novel analyt...
The increasing global burden of cardiometabolic diseases highlights the urgent clinical need for bet...
Dysregulation of lipid metabolism plays a major role in the etiology and sequelae of inflammatory di...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
Background— The bulk of cardiovascular disease risk is not explained by traditional risk factors. Re...
The metabolic syndrome (MetS) is a cluster of cardiovascular risk factors characterised by central o...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
Background: Advances in mass spectrometry and lipidomics techniques are providing new insights into ...
Introduction: Blood-based sample collection is a challenge, and dried blood spots (DBS) represent an...
Increased plasma cholesterol is a known risk factor for cardiovascular disease. Lipoprotein particle...
Motivation: Serum lipids have been traditionally studied in the context of lipoprotein particles. To...
Monitoring cholesterol levels is strongly recommended to identify patients at risk for myocardial in...
Abstract Background: Quantitative lipoprotein analytics using nuclear magnetic resonance (NMR) spec...
Lipids are ubiquitous in the human organism and play essential roles as components of cell membranes...
Obesity is associated with changes in the plasma lipids. Although simple lipid quantification is rou...
The focus of the present study was to define the human plasma lipidome and to establish novel analyt...
The increasing global burden of cardiometabolic diseases highlights the urgent clinical need for bet...
Dysregulation of lipid metabolism plays a major role in the etiology and sequelae of inflammatory di...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
Background— The bulk of cardiovascular disease risk is not explained by traditional risk factors. Re...
The metabolic syndrome (MetS) is a cluster of cardiovascular risk factors characterised by central o...
A systematic approach is described for building validated PLS models that predict cholesterol and tr...
Background: Advances in mass spectrometry and lipidomics techniques are providing new insights into ...
Introduction: Blood-based sample collection is a challenge, and dried blood spots (DBS) represent an...
Increased plasma cholesterol is a known risk factor for cardiovascular disease. Lipoprotein particle...